During the submission of our manuscript, it was reported that Zou et al. developed DNA methylation signature for CD8+ TILs that could assess CD8+ TILs in colorectal cancers, using three individual CpG sites that are located in the low-CpG density regions and highly differentially methylated between CD8+ T cells and other cells20. Here, CD8A is linked to colorectal cancer.